welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
Dennis J. Ahnen, MD
Professor of Medicine
Division of Gastroenterology
University of Colorado
12631 E. 17th Ave. B158
Aurora, Colorado, United States
Dr. Ahnen’s research interess include the biologic and the biochemical mechanisms of the chemopreventive effects of the non-steroidal anti-inflammatory drugs (NSAIDs). He is currently examining the effect of NSAIDs on EGF receptor expression and function. His clinical trials group participates in several colorectal cancer prevention trials including several adenoma chemoprevention trials. He also collaborates with Al Marcus PhD and staff at the AMC Cancer Research Center to evaluate behavioral interventions to increase colorectal cancer screening rates in high-risk populations and he directs the Colorado site for two national cancer registries that identify high risk families for genetic and clinical trials.
Undergraduate: Florida State University
Medical School: Wayne State University
Fellowship: Gastroenterology University of Colorado Denver
Fellowship: Membrane Pathobiology, Stanford University
expertly curated content related to this topic
Robert E. Schoen, MD, MPHRobert E. Schoen, MD, MPH is Professor o...
St. Mark’s Hospital/Polyposis RegistryPatient Resources: Polyposis Regist...
Amy A. Irving, PhDAmy A. Irving, PhD from University of Wi...
Dana Sands, MDDana R. Sands, MD, FACS, FASCRS, is a Su...
Sue Clark, MDSue Clark trained in medicine at Cambrid...
Steven GallingerHead of the Hepatobiliary and pancreatic...
Celecoxib, DFMO combination improved adenoma burden in patients with familial adenomatous polyposisIn a randomized clinical chemoprevention...